UNICEF and PAHO have placed long-term supply orders with the biotechnology company for its WHO-pre-qualified completely liquid pentavalent vaccination, Easyfive-TT, totaling $127.3 million (Rs1,040 crore).
At around 1.10 PM, Panacea Biotec was trading 17.54% higher at Rs157.50, against the previous close of Rs134 on NSE.
The orders from UNICEF and PAHO each total $98.755 million (Rs 813 crore) for the delivery of 99.70 million doses over the course of the calendar years 2023—2027 and $28.55 million (Rs 235 crore) for the supply of 24.83 million doses over the course of the calendar years 2023—2025, respectively.
The order victory exceeds the small-cap company's whole market capitalisation of Rs955 crore.
Even after a chunky 20% surge, the counter was trading much lower than its 52-week high of Rs286. However, during today’s intraday trade it hit the upper circuit limit of Rs160.80.
On a year-to-date basis, the company's shares have been down more than 20%, while over the last year, they have declined approximately 45%.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.